Emerging parasitic infections in transplantation

Current Infectious Disease Reports

Volumn 14, Issue 6, 2012, Pages 642-649

  Lattes, Roberta ^a   Linares, Laura ^a   Radisic, Marcelo ^a  

^a Instituto de Nefrologia Buenos Aires ar   (Argentina)

Author keywords

Chagas disease; Echinococcal diseases; Free living amebas; Leishmaniasis; Malaria; Microsporidia; Parasitic infections; Strongyloides

Indexed keywords

ALBENDAZOLE; AMIODARONE; AMPHOTERICIN B LIPID COMPLEX; ARTEMISININ DERIVATIVE; ARTESUNATE; ATOVAQUONE; BENZNIDAZOLE; CHLOROQUINE; CLINDAMYCIN; CYCLOSPORIN; DNA; DOXYCYCLINE; FUMAGILLIN; HALOFANTRINE; IVERMECTIN; MEFLOQUINE; MILTEFOSINE; NIFURTIMOX; PARASITE ANTIBODY; PARASITE ANTIGEN; POSACONAZOLE; PROGUANIL; QUININE; RAVUCONAZOLE; TACROLIMUS; TIABENDAZOLE;

AMEBIASIS; ARTICLE; CHAGAS DISEASE; CLINICAL FEATURE; DNA DETERMINATION; DRUG ANTAGONISM; DRUG BLOOD LEVEL; ECHINOCOCCOSIS; ENDEMIC DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; INFECTION RISK; MALARIA; MALARIA FALCIPARUM; MICROSPORIDIOSIS; NONHUMAN; ORGAN TRANSPLANTATION; PARASITE CLEARANCE; PARASITE IDENTIFICATION; PARASITE TRANSMISSION; PARASITE VECTOR; PARASITOSIS; PLASMODIUM MALARIAE INFECTION; PLASMODIUM OVALE MALARIA; PLASMODIUM VIVAX MALARIA; POSTOPERATIVE INFECTION; STRONGYLOIDIASIS; SURGICAL RISK; TREATMENT OUTCOME; TRYPANOSOMA CRUZI; VISCERAL LEISHMANIASIS;

EID: 84870548397     PISSN: 15233847     EISSN: 15343146     Source Type: Journal    
DOI: 10.1007/s11908-012-0295-z     Document Type: Article

References (53)

1. Kotton CN, Lattes R. Parasitic infections in solid organ transplantation. Am J Transpl. 2009;9(s4):s234-51.
2. Muñoz P, Valerio M, Eworo A, Bouza E. Parasitic infections in solid-organ recipients. Curr Opin Organ Transplant. 2011;16 (6):565-75. Updated perspective of the most common parasitic diseases occurring in solid organ transplant. Includes a thorough review of published papers.
3. Centers for Disease Control and Prevention (CDC). Notes from the field: transplant-Transmitted Balamuthia mandrillaris -Arizona, 2010. MMWR Morb Mortal Wkly Rep. 2010;59(36):1182.
4. Barsoum RS. Parasitic infections in organ transplantation. Exp Clin Transplant. 2004;2(2):258-67.
5. Antinori S, Cascio A, Parravicini C, Bianchi R, Corbellino M. Leishmaniasis among organ transplant recipients. Lancet Infect Dis. 2008;8(3):191-9.
6. Simon I, Wissing KM, Del Marmol V, Antinori S, Remmelink M, Nilufer Broeders E, Nortier JL, Corbellino M, Abramowicz D, Cascio A. Recurrent leishmaniasis in kidney transplant recipients: report of 2 cases and systematic review of the literature. Transpl Infect Dis. 2011;13:397-406.
7. Bern C, Montgomery SP. An estimate of the burden of Chagas disease in the United States. Clin Infect Dis. 2009;49:e52-4.
8. The Chagas' Disease Argentine Collaborative Transplant Consortium, Casadei D. Chagas' disease and solid organ transplantation. Transpl Proc. 2010;42:3354-9. Data on follow-up of infected recipients and of naive recipients transplanted with organs from infected donors in large transplant centers from an endemic area. Guidelines on follow-up after transplantation.
9. OtaniM, Vinelli E, Kirchhoff L, et al. WHO comparative evaluation of serologic assays for Chagas disease. Transfusion. 2009;49:1076-82. Comprehensive comparison of different serological diagnostic methods with evaluation of sensitivity and specificity of available tests.
10. Pirard M, Iihoshi N, Boelaert M, et al. The validity of serologic tests for Trypanosoma cruzi and the effectiveness of transfusional screening strategies in a hyperendemic region. Transfusion. 2005;45 (4):554-61.
11. Gorlin J, Rossmann S, Robertson G, et al. Evaluation of a new Trypanosoma cruzi antibody assay for blood donor screening. Transfusion. 2008;48(3):531-40.
12. Schijman AG, Bisio M, Orellana L, et al. International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients. PLoS Negl Trop Dis. 2011;5(1):e931. Intralaboratory and interlaboratory comparison of different PCR primers to evaluate those with the highest correlation to known positive samples.
13. Rodriques Coura J, de Castro SL. A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz. 2002;97(1):3-24.
14. Sosa Estani S, Segura EL. Treatment of Trypanosoma cruzi infection in the undetermined phase. Experience and current guidelines of treatment in Argentina. Mem Inst Oswaldo Cruz. 1999;94 Suppl 1:363-5.
15. Amato Neto V. Etiological treatment for infection by Trypanosoma cruzi. Mem Inst Oswaldo Cruz. 1999;94 Suppl 1:337-9.
16. Viotti R, Vigliano C, Lococo B, et al. Long-Term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment. Ann Intern Med. 2006;144:724-34.
17. Viotti R, Vigliano C. Etiological treatment of chronic Chagas disease: neglected 'evidence' by evidence-based medicine. Expert Rev Anti Infect Ther. 2007;5(4):717-26.
18. Marin-Neto JA, Rassi Jr A, Avezum Jr A, et al. The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease. Mem Inst Oswaldo Cruz. 2009;104 Suppl 1:319-24.
19. Le Loup G, Pialoux G, Lescure FX. Update in the treatment of Chagas disease. Curr Opin Infect Dis. 2011;24(5):428-34.
20. Bern C. Antitrypanosomal therapy for chronic Chagas' disease. N Engl J Med. 2011;364:2527-34. A thorough review of the most important issues of the disease with an exhaustive review of available treatments and ongoing treatment protocols.
21. Veiga-Santos P, Barrias ES, Santos JF, et al. Effects of amiodarone and posaconazole on the growth and ultrastructure of Trypanosoma cruzi. Int J Antimicrob Agents. 2012;40(1):61-71.
22. Chin-Hong P, Schwartz BS, Bern C, et al. Screening and treatment of Chagas disease in organ transplant recipients in the United States: recommendations from the Chagas working group. Am J Transplant. 2011;11(4):672-80. Thorough review of available methods for screening and for diagnosis.
23. Riarte A, Luna C, Sabatiello R, et al. Chagas' disease in patients with kidney transplants: 7 years of experience 1989-1996. Clin Infect Dis. 1999;29(3):561-7.
24. Diez M, Favaloro L, Bertolotti A, et al. Usefulness of PCR strategies for early diagnosis of Chagas' disease reactivation and treatment follow-up in heart transplantation. Am J Transplant. 2007;7(6):1633-40. The first comparison of parasitemia diagnosis in the transplant setting using standard methods vs PCR.
25. Bocchi EA, Fiorelli A. The paradox of survival results after heart transplantation for cardiomyopathy caused by Trypanosoma cruzi. First Guidelines Group for Heart Transplantation of the Brazilian Society of Cardiology. Ann Thorac Surg. 2001;71(6):1833-8.
26. Godoy HL, Guerra C, Viegas RF, et al. Infections in heart transplant recipients in Brazil: the challenge of Chagas' disease. J Heart Lung Transplant. 2010;29(3):286-90.
27. Campos SV, Strabelli TM, Amato Neto V, et al. Risk factors for Chagas' disease reactivation after heart transplantation. J Heart Lung Transplant. 2008;27(6):597-602.
28. Fiorelli AI, Santos RHB, Oliveira Jr JL, et al. Heart transplantation in 107 cases of Chagas' disease. Transplant Proc. 2011;43(1):220-4.
29. de Faria JB, Alves G. Transmission of Chagas' disease through cadaveric renal transplantation. Transplantation. 1993;56(3):746-7.
30. Vazquez MC, Riarte A, Pattin M, Lauricella M. Chagas' disease can be transmitted through kidney transplantation. Transplant Proc. 1993;25(6):3259-60.
31. Zayas CF, Perlino C, Caleindo A, et al. Chagas disease after organ transplantation -United States, 2001. MMWR Morb Mortal Wkly Rep. 2002;51:210-2.
32. Centers for Disease Control and Prevention (CDC). Chagas disease after organ transplantation -Los Angeles, California, 2006.
33. MMWR Morb Mortal Wkly Rep. 2006;55(29):798-800.
34. McCormack L, Quiñonez E, Goldaracena N, et al. Liver transplantation using Chagas-infected donors in uninfected recipients: a single-center experience without prophylactic therapy. Am J Transpl. 2012. doi:10.1111/j.1600-6143.2012.04160.x.
35. Altclas JD, Barcan L, Nagel C, Lattes R, Riarte A. Organ transplantation and Chagas disease. JAMA. 2008;299(10):1134.
36. Mungai M, Tegtmeier G, Chamberland M, Parise M. Transfusiontransmitted malaria in the United States from 1963 through 1999. N Engl J Med. 2001;344(26):1973-8.
37. Montes M, Sawhney C, Barros N. Strongyloides stercoralis: there but not seen. Curr Opin Infect Dis. 2010;23(5):500-4.
38. Roxby AC, Gottlieb GS, Limaye AP. Strongyloidiasis in transplant patients. Clin Infect Dis. 2009;49(9):1411-23. Comprehensive review of Strongyloides infection in the transplant setting.
39. Patel G, Arvelakis A, Sauter BV, Gondolesi GE, Caplivski D, Huprikar S. Strongyloides hyperinfection syndrome after intestinal transplantation. Transpl Infect Dis. 2008;10(2):137-41.
40. Hamilton KW, Abt PL, Rosenbach MA, et al. Donor-derived Strongyloides stercoralis infections in renal transplant recipients. Transplantation. 2011;91(9):1019-24. Demonstration of transmission from donor in kidney recipients. Hypothesis on what might the causes be.
41. Tarr P, Miele PS, Peregoy KS, Smith MA, Neva FA, Lucey DR. Case report: rectal administration of ivermectin to a patient with Strongyloides hyperinfection syndrome. AmJTrop Med Hyg. 2003;68:453-5.
42. Lichtenberger P, Rosa-Cunha I, Morris M, et al. Hyperinfection strongyloidiasis in a liver transplant recipient treated with parenteral ivermectin. Transpl Infect Dis. 2009;11:137-42.
43. Didier ES, Weiss LM. Microsporidiosis: current status. Curr Opin Infect Dis. 2006;19(5):485-92.
44. Rabodonirina M, Cotte L, Radenne S, Besada E, Trepo C. Microsporidiosis and transplantation. A retrospective study of 23 cases. J Eukaryot Microbiol. 2003;50(Suppl):583.
45. Galvan AL, Sanchez AM, Valentin MA, et al. First cases of microsporidiosis in transplant recipients in Spain and review of the literature. J Clin Microbiol. 2011;49(4):1031-6.
46. Fung KT, Dhillon AP, McLaughlin JE. Cure of Acanthamoeba cerebral abscess in a liver transplant patient. Liver Transpl. 2008;14(3):308-12.
47. Vernon SE, Acar BC, Pham SM, Fertel D. Acanthamoeba infection in lung transplantation: report of a case and review of the literature. Transpl Infect Dis. 2005;7(3/4):154-7.
48. Duarte AG, Sattar F, Granwerh B, Aronson JF, Wang Z, Lick S. Disseminated acanthamoebiasis after lung transplantation. J Heart Lung Transplant. 2006;25(2):237-40.
49. Barete S, Combes A, de Jonckheere JF, et al. Fatal disseminated Acanthamoeba lenticularis infection in a heart transplant patient. Emerg Infect Dis. 2007;13(5):736-8.
50. Centers for Disease Control and Prevention (CDC). Balamuthia mandrillaris transmitted through organ transplantation -Mississippi, 2009. MMWR Morb Mortal Wkly Rep. 2010;59(36):1165-70.
51. Kern P, Grüner B, Wahlers K. Diagnosis and course of echinococcal diseases in the transplant setting. Transpl Infect Dis. 2011;13:217-21.
52. Bresson-Hadni S, Vuitton DA, Bartholomot B, et al. A twenty-year history of alveolar echinococcosis: analysis of a series of 117 patients from eastern France. Eur J Gastroenterol Hepatol. 2000;12:327-36.
53. Geyer M, Wilpert J, Wiech T, et al. Rapidly progressive hepatic alveolar echinococcosis in an ABO-incompatible renal transplant recipient. Transpl Infect Dis. 2011;13(3):278-84.